425: Core Scientific to Merge with CoreWeave in All-Stock Transaction

Core Scientific, a leading blockchain infrastructure company, has entered into a definitive merger agreement to be acquired by CoreWeave, a specialized cloud provider, in an all-stock transaction at an exchange ratio of 0.1235 shares of CoreWeave Class A common stock for each Core Scientific share.

Summary

• Core Scientific, Inc. (the Company) has entered into an Agreement and Plan of Merger with CoreWeave, Inc. (Parent) and Miami Merger Sub I, Inc., a wholly-owned subsidiary of CoreWeave.
• Upon closing, Merger Sub will merge into Core Scientific, with Core Scientific surviving as a wholly-owned subsidiary of CoreWeave.
• Each share of Core Scientific common stock (CORZ) will be converted into the right to receive 0.1235 fully paid and non-assessable shares of CoreWeave Class A common stock (Parent Class A Common Stock).
• Company RSU Awards and Company PSU Awards held by specified individuals (including Adam Sullivan, Jim Nygaard, and Todd DuChene) and non-employee directors will fully vest and convert into Parent Class A Common Stock at the Exchange Ratio, with PSU awards deemed to have achieved 300% performance.
• Other Company RSU Awards will convert into Parent Rollover RSU Awards, subject to substantially the same vesting and forfeiture conditions.
• Other Company PSU Awards will convert into time-based Parent Rollover PSU Awards, deemed to have achieved 300% performance, with service vesting dates of December 31, 2026 (for 2024 grants) or December 31, 2027 (for 2025 grants).
• In-the-money Company Options will be cancelled and converted into Parent Class A Common Stock based on a formula, while out-of-the-money options will be cancelled without consideration.
• Company Warrants (Tranche 1 and Tranche 2) will convert into New Tranche 1 Warrants and New Tranche 2 Warrants, respectively, exercisable for Parent Class A Common Stock with adjusted exercise prices.
• CoreWeave will assume Core Scientific's obligations under the Contingent Value Rights Agreement.
• The merger is subject to customary closing conditions, including Core Scientific stockholder approval, effectiveness of CoreWeave's S-4 registration statement, HSR Act clearance, absence of injunctions, and Nasdaq listing approval for the new CoreWeave shares.
• Core Scientific will pay CoreWeave a termination fee of $270,000,000 under specific circumstances, such as an Adverse Recommendation Change or termination to pursue a Superior Proposal.

Sentiment

Score: 8

Explanation: The announcement of a definitive merger agreement is a strong positive signal for strategic growth and shareholder value realization. The unanimous board approvals from both companies indicate strong internal alignment. While there are standard merger-related risks and a substantial termination fee, the overall tone and nature of the transaction suggest a well-planned strategic move into a high-growth sector (AI/HPC) for the combined entity, offering a clear path forward for Core Scientific shareholders.

Positives

• The merger provides Core Scientific shareholders with a stake in CoreWeave, a specialized cloud provider, potentially offering exposure to a different growth trajectory.
• The Core Scientific Board of Directors unanimously determined the merger is advisable, fair, and in the best interests of the Company and its stockholders.
• CoreWeave's Board of Directors also unanimously approved the transaction, indicating strong internal support for the acquisition.
• Equity awards for specified individuals and non-employee directors of Core Scientific will fully vest upon closing, providing immediate value.
• Other Company PSU Awards will convert at a 300% performance level, potentially benefiting employees more than their original terms.

Negatives

• The merger involves a fixed exchange ratio, meaning Core Scientific shareholders' value is tied to CoreWeave's stock performance post-merger.
• Named executive officers will separate from employment at closing, which could lead to leadership transition challenges.
• The termination fee of $270,000,000 is substantial and would be payable by Core Scientific under certain conditions, including pursuing a superior proposal, potentially limiting flexibility.

Risks

• Completion of the proposed transaction on anticipated terms or at all, and the timing thereof, including obtaining required regulatory approvals and Core Scientific stockholder approval.
• Unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the combined company.
• The possibility that anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• Ability of Core Scientific and CoreWeave to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against Core Scientific, CoreWeave, or their respective directors and officers.
• Disruptions from the proposed transaction harming Core Scientific's or CoreWeave's business, including current plans and operations, and diversion of management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and the companies' ability to access debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Changes in local, national, or international laws, regulations, and policies affecting Core Scientific and CoreWeave.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• Impacts of pandemics or other public health crises, including government responses.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at Core Scientific and/or CoreWeave's data center sites, including delays in converting crypto mining facilities to high-performance computing sites.
• Core Scientific's ability to earn digital assets profitably and to attract customers for its high-density colocation capabilities.
• Core Scientific's ability to perform under its existing colocation agreements and maintain its competitive position.
• The impact of increases in total network hash rate.
• Core Scientific's ability to raise additional capital for expansion efforts or other operations.
• Core Scientific's need for significant electric power and the limited availability of power resources.
• Potential failure in Core Scientific's critical systems, facilities, or services.
• Physical risks and regulatory changes relating to climate change.
• Potential significant changes to the method of validating blockchain transactions.
• Core Scientific's vulnerability to physical security breaches.
• A potential slowdown in market and economic conditions, particularly those impacting high-density computing, the blockchain industry, and the blockchain hosting market.
• Price volatility of digital assets, especially bitcoin.
• Potential changes in the interpretive positions of the SEC or its staff with respect to digital asset mining firms.
• The likelihood that U.S. federal and state legislatures and regulatory agencies will enact laws and regulations to regulate digital assets and digital asset intermediaries.
• Changing expectations with respect to ESG policies.
• The effectiveness of Core Scientific's compliance and risk management methods.
• The adequacy of Core Scientific's sources of recovery if digital assets held by Core Scientific are lost, stolen, or destroyed due to third-party digital asset services.

Future Outlook

The document outlines the strategic intent for the merger to qualify as a tax-free reorganization. The combined entity aims to integrate businesses successfully and achieve anticipated synergies. There is an expectation of converting data center sites from crypto mining to high-performance computing, aligning with industry trends. The future outlook is contingent on obtaining regulatory approvals, stockholder approval, and successful integration, with a target closing date by April 7, 2026.

Management Comments

• The Company Board unanimously determined that the Agreement and the Contemplated Transactions are advisable, fair to, and in the best interests of the Company and its stockholders.
• The Company Board approved and deemed advisable the execution and delivery of the Agreement, the performance by the Company of its covenants and agreements, and the consummation of the Contemplated Transactions, including the Merger.
• The Company Board directed that the adoption of the Agreement be submitted to a vote at a meeting of the Company Stockholders and resolved to recommend that the Company Stockholders approve the Merger and adopt the Agreement.
• The Parent Board unanimously determined that the Agreement and the Contemplated Transactions are advisable and in the best interests of Parent and its stockholders.
• The Parent Board approved and deemed advisable the execution and delivery of the Agreement, the performance by Parent of its covenants and agreements, and the consummation of the Contemplated Transactions, including the Merger and the issuance of shares of Parent Class A Common Stock, New Tranche 1 Warrants, and New Tranche 2 Warrants.

Industry Context

This merger reflects a significant strategic move within the evolving digital infrastructure sector. Core Scientific, traditionally a crypto mining and colocation provider, is merging with CoreWeave, a specialized cloud provider focusing on high-performance computing (HPC) for AI workloads. This transaction aligns with a broader industry trend of diversifying from pure crypto mining, which is subject to high volatility in digital asset prices and energy costs, towards more stable and high-demand services like AI-driven HPC. The mention of converting crypto mining facilities to HPC sites highlights this strategic pivot, leveraging existing infrastructure for new, high-growth applications in the artificial intelligence and data center industries.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Potential litigation relating to the proposed transaction that could be instituted against Core Scientific, CoreWeave, or their respective directors and officers is identified as a risk factor.

Related Party Transactions

• Excise tax reimbursement agreements approved for named executive officers and certain other executives of Core Scientific, providing gross-up payments for Section 4999 excise tax liabilities related to the Merger.
• Individual letter agreements approved for named executive officers and certain other executives of Core Scientific, detailing severance payments and equity award vesting upon separation from employment at the Merger's closing.

Stakeholder Impact

• Shareholders of Core Scientific will receive CoreWeave Class A Common Stock, providing them with a stake in the combined entity and its strategic direction towards high-performance computing.
• Shareholders of CoreWeave will experience dilution due to the issuance of new shares as merger consideration.
• Named executive officers of Core Scientific will receive significant severance and accelerated equity vesting upon their separation from employment at closing.
• Other Core Scientific employees will receive comparable annual base salary/wages and target cash incentive opportunities for one year post-merger, along with substantially comparable employee benefits and recognition of prior service for new plans.
• Customers and suppliers of Core Scientific are expected to maintain their business relationships, with efforts to preserve current business organizations.
• Creditors related to Core Scientific's convertible notes and secured debt documents will see their instruments converted or assumed by CoreWeave, or liens released, as part of the transaction.

Next Steps

• Obtain Core Scientific Stockholder Approval for the merger.
• CoreWeave to file a registration statement on Form S-4 with the SEC, which must become effective.
• Core Scientific to prepare and mail a proxy statement to its stockholders.
• Expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
• Approval for listing of CoreWeave Class A Common Stock, New Tranche 1 Warrants, and New Tranche 2 Warrants on the Nasdaq Global Select Market.
• Core Scientific to take actions to cause account balances of current and former employees under the PEO 401(k) plan to be spun off into a separate Company 401(k) Plan.
• If the Company 401(k) Plan spin-off is completed, Core Scientific to terminate the Company 401(k) Plan effective no later than the day immediately preceding the Closing Date.
• CoreWeave to make Core Scientific employees eligible to participate in a Parent 401(k) Plan and allow rollover contributions.
• Parent to post a duly completed IRS Form 8937 on its website not later than forty-five (45) days after the Closing Date.
• Core Scientific to cooperate with Parent to delist Company Common Stock and Warrants from Nasdaq and deregister them under the Exchange Act after the Effective Time.

Key Dates

Recommendation

Keywords

Merger, Acquisition, Core Scientific, CoreWeave, Blockchain, High-Performance Computing, Data Center, Crypto Mining, SEC Filing, Stock-for-Stock, Corporate Governance, Risk Management, Strategic Alliance, Digital Assets, Nasdaq